Serum levels of long-chain polyunsaturated fatty acids in patients with periodontal disease

Journal of Periodontology

Volumn 84, Issue 5, 2013, Pages 675-682

  Figueredo, Carlos Marcelo ^a,b   Martinez, Gisele L ^a   Koury, Josely C ^a   Fischer, Ricardo G ^a   Gustafsson, Anders ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arachidonic acid; Docosahexaenoic acids; Eicosapentaenoic acid; Inflammation mediators; Periodontal diseases; Unsaturated fatty acids

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; UNSATURATED FATTY ACID;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; DIET; FEMALE; GAS CHROMATOGRAPHY; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SEA FOOD;

ADULT; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, GAS; CHRONIC PERIODONTITIS; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FEMALE; FISH PRODUCTS; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 84877129407     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120171     Document Type: Article

References (50)

1. Page RC, Beck JD. Risk assessment for periodontal diseases. Int Dent J 1997;47:61-87.
2. Van Dyke TE, Serhan CN. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003;82:82-90.
3. Iwasaki M, Yoshihara A, Moynihan P, Watanabe R, Taylor GW, Miyazaki H. Longitudinal relationship between dietary v-3 fatty acids and periodontal disease. Nutrition 2010;26:1105-1109.
4. Iwasaki M, Taylor GW, Moynihan P, et al. Dietary ratio of n-6 to n-3 polyunsaturated fatty acids and periodontal disease in community-based older Japanese: A 3-year follow-up study. Prostaglandins Leukot Essent Fatty Acids 2011;85:107-112.
5. Naqvi AZ, Buettner C, Phillips RS, Davis RB, Mukamal KJ. n-3 fatty acids and periodontitis in US adults. J Am Diet Assoc 2010;110:1669-1675.
6. Ramirez-Tortosa MC, Quiles JL, Battino M, et al. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc Dis 2010;20:133-139.
7. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B. Serum fatty acid imbalance in bone loss: Example with periodontal disease. Clin Nutr 2000;19: 271-276.
8. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-150.
9. Lands B. A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res 2008;47:77-106.
10. Lemmon MA. Membrane recognition by phospholipidbinding domains. Nat Rev Mol Cell Biol 2008;9:99-111.
11. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008;9:162-176.
12. Calder PC. Fatty acids and inflammation: The cutting edge between food and pharma. Eur J Pharmacol 2011;668(Suppl. 1):S50-S58.
13. Sprecher H. Metabolismof highly unsaturated n-3 and n-6 fattyacids. BiochimBiophysActa 2000;1486:219-231.
14. Ott J, Hiesgen C, Mayer K. Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 2011;85:267-273.
15. Sijben JW, Calder PC. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007;66:237-259.
16. Mayer K, Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 2008;11:121-127.
17. Calder PC. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003;38:343-352.
18. Hjartaker A, Lund E, Bjerve KS. Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 1997;51: 736-742.
19. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M, Tsugane S. Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-Aged Japanese men. Eur J Clin Nutr 2001;55:643-650.
20. Maruyama C, Yoneyama M, Suyama N, et al. Differences in serum phospholipid fatty acid compositions and estimated desaturase activities between Japanese men with and without metabolic syndrome. J Atheroscler Thromb 2008;15:306-313.
21. Novgorodtseva TP, Karaman YK, Zhukova NV, Lobanova EG, Antonyuk MV, Kantur TA. Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids Health Dis 2011;10:82.
22. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005;82: 1178-1184.
23. Campan P, Planchand PO, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol 1997;24: 907-913.
24. Rosenstein ED, Kushner LJ, Kramer N, Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 2003;68:213-218.
25. Elkhouli AM. The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). J Periodontal Res 2011;46:261-268.
26. El-Sharkawy H, Aboelsaad N, Eliwa M, et al. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and lowdose aspirin. J Periodontol 2010;81:1635-1643.
27. Vardar S, Buduneli E, Turkoglu O, et al. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats. J Periodontol 2004;75:1640-1646.
28. Kesavalu L, Bakthavatchalu V, Rahman MM, et al. Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease. Oral Microbiol Immunol 2007;22:232-239.
29. Vardar-Sengul S, Buduneli N, Buduneli E, et al. Dietary supplementation of omega-3 fatty acid and circulating levels of interleukin-1beta, osteocalcin, and C-reactive protein in rats. J Periodontol 2006;77:814-820.
30. Kesavalu L, Vasudevan B, Raghu B, et al. Omega-3 fatty acid effect on alveolar bone loss in rats. J Dent Res 2006;85:648-652.
31. Bendyk A, Marino V, Zilm PS, Howe P, Bartold PM. Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse. J Periodontal Res 2009;44:211-216.
32. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
33. Bhattacharya A, Lawrence RA, Krishnan A, Zaman K, Sun D, Fernandes G. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice. J Am Coll Nutr 2003;22:388-399.
34. Kennedy ET, Luo H, Ausman LM. Cost implications of alternative sources of (n-3) fatty acid consumption in the United States. J Nutr 2012;142:605S-609S.
35. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: Are effects of EPA and DHA shared or complementary? J Nutr 2012;142:614S-625S.
36. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-2497.
37. Zubery Y, Dunstan CR, Story BM, et al. Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect Immun 1998;66:4158-4162.
38. Zhou L, Nilsson A. Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res 2001;42:1521-1542.
39. Kantarci A, Van Dyke TE. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids 2005;73: 289-299.
40. Badr KF, DeBoer DK, Schwartzberg M, Serhan CN. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: Evidence for competition at a common receptor. Proc Natl Acad Sci USA 1989;86:3438-3442.
41. Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, Van Dyke TE. Impaired phagocytosis in localized aggressive periodontitis: Rescue by Resolvin E1. PLoS ONE 2011;6:e24422.
42. Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006;17: 22-27.
43. Baylin A, Kim MK, Donovan-Palmer A, et al. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: Comparison with adipose tissue and plasma. Am J Epidemiol 2005; 162:373-381.
44. Rizzo AM, Montorfano G, Negroni M, et al. A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: Correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. Lipids Health Dis 2010;9:7.
45. Dawczynski C, Hackermeier U, Viehweger M, Stange R, Springer M, Jahreis G. Incorporation of n-3 PUFA and g-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis -A randomized controlled human intervention trial. Lipids Health Dis 2011;10:130.
46. Levy-Costa RB, Sichieri R, Pontes NdosS, Monteiro CA. [Household food availability in Brazil: Distribution and trends (1974-2003)]. Rev Saude Publica 2005;39: 530-540.
47. WHO(World Health Organization).WHOand FAO joint consultation: Fats and oils in human nutrition. Nutr Rev 1995;53:202-205.
48. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008;233:674-688.
49. Hasturk H, Kantarci A, Goguet-Surmenian E, et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007;179:7021-7029.
50. Korhonen S, Saxlin T, Suominen L, Jula A, Knuuttila M, Ylostalo P. Serum cholesterol ratios and periodontal infection: Results of the Health 2000 Survey. J Clin Periodontol 2011;38:787-794.